Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

13.58
+0.08000.59%
Post-market: 13.53-0.0500-0.37%19:48 EDT
Volume:2.36M
Turnover:31.84M
Market Cap:2.09B
PE:-34.63
High:13.60
Open:13.36
Low:13.18
Close:13.50
52wk High:20.76
52wk Low:6.68
Shares:153.78M
Float Shares:117.37M
Volume Ratio:1.02
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3922
EPS(LYR):-0.3922
ROE:-27.82%
ROA:-6.79%
PB:9.54
PE(LYR):-34.63

Loading ...

Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal?

Benzinga_recent_news
·
Dec 06, 2025

Adaptive Biotechnologies (ADPT) Is Down 11.2% After Earnings Beat And CFO Share Sale - Has The Bull Case Changed?

Simply Wall St.
·
Dec 06, 2025

Morgan Stanley Raises Price Target on Adaptive Biotechnologies to $21 From $16, Keeps Equalweight Rating

MT Newswires Live
·
Dec 02, 2025

Adaptive Biotechnologies CEO and Chairman Chad M. Robins Reports Disposal of Common Shares

Reuters
·
Dec 02, 2025

Adaptive Biotechnologies Showcases clonoSEQ MRD Testing in 89 Abstracts at ASH 2025

Reuters
·
Nov 24, 2025

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring Clonoseq® Mrd Testing Across a Range of Blood Cancers to Be Presented at the 67TH Ash Annual Meeting

THOMSON REUTERS
·
Nov 24, 2025

Adaptive Biotechnologies rises 11.3%

TIPRANKS
·
Nov 22, 2025

Adaptive Biotechnologies (ADPT) Is Up 15.4% After Raising Guidance on Strong MRD Test Momentum Has the Bull Case Changed?

Simply Wall St.
·
Nov 21, 2025

Adaptive Biotechnologies Currently Down Nine Consecutive Days, on Pace for Longest Losing Streak Since August 2023 -- Data Talk

Dow Jones
·
Nov 19, 2025

Chad M. Robins Reports Sale of Adaptive Biotechnologies Common Shares

Reuters
·
Nov 13, 2025

Adaptive Biotechnologies Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Nov 12, 2025

Adaptive Biotechnologies Is Maintained at Buy by BTIG

Dow Jones
·
Nov 07, 2025

Adaptive Biotechnologies Corporation to Present at Jefferies Global Healthcare Conference

Reuters
·
Nov 07, 2025

Adaptive Biotechnologies (ADPT) Gets a Buy from Craig-Hallum

TIPRANKS
·
Nov 06, 2025

Stock Track | Adaptive Biotechnologies Soars 5.23% Pre-market on Strong Q3 Results and Analyst Upgrades

Stock Track
·
Nov 06, 2025

Stock Track | Adaptive Biotechnologies Soars 5.23% Pre-market on Strong Q3 Results and Analyst Upgrades

Stock Track
·
Nov 06, 2025

Adaptive Biotechnologies Corp : JP Morgan Raises Target Price to $20 From $17

THOMSON REUTERS
·
Nov 06, 2025

U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin, Centuri Holdings

Reuters
·
Nov 06, 2025

Adaptive Biotechnologies Corp : TD Cowen Raises Target Price to $22 From $18

THOMSON REUTERS
·
Nov 06, 2025

Adaptive Biotechnologies Corp reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 06, 2025